If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......
Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control......
Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......
India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
The country's first messenger mRNA vaccine is expected to begin trials on humans in February. IMAGE: A health worker administers a dose of COVID-19 vaccine to a beneficiary during a vaccination......